Long Circulating Liposomes: Old Drugs, New Therapeutics

  • Martin C. Woodle
  • Gerrit Storm

Part of the Biotechnology Intelligence Unit book series (BIOIU)

Table of contents

  1. Front Matter
    Pages i-xx
  2. Introduction

    1. Front Matter
      Pages 1-1
  3. Current Medical Applications

    1. Front Matter
      Pages 17-17
    2. Malignant Diseases

      1. Nancy L. Boman, Pieter R. Cullis, Lawrence D. Mayer, Marcel B. Bally, Murray S. Webb
        Pages 29-49
      2. Timo L. M. ten Hagen, Alexander H. van der Veen, Alexander M. M. Eggermont
        Pages 51-60
      3. Mark Harrison, K. J. Harrington, J. S. W. Stewart
        Pages 111-125
      4. Geoffrey Mukwaya, Eric A. Forssen, Paul Schmidt, Michael Ross
        Pages 147-163
      5. Alberto A. Gabizon, Franco M. Muggia
        Pages 165-174
    3. Other Therapeutic Applications

      1. Irma A. J. M. Bakker-Woudenberg, Gerrit Storm, Martin C. Woodle
        Pages 177-183
      2. Jill P. Adler-Moore, Richard T. Proffitt
        Pages 185-206
      3. Robert M. Fielding, Geoffrey Mukwaya, Robert A. Sandhaus
        Pages 213-225
    4. Diagnostics

      1. Otto C. Boerman, Wim J. G. Oyen, Frans H. M. Corstens, Gerrit Storm
        Pages 229-240
      2. Vladimir S. Trubetskoy, Vladimir P. Torchilin
        Pages 241-255
  4. Future Medical Applications: Surface Ligands and Targeting

    1. Front Matter
      Pages 267-267
    2. Alexander L. Klibanov
      Pages 269-286
    3. Martin C. Woodle, Danilo D. Lasic, Gerrit Storm
      Pages 287-295
  5. Back Matter
    Pages 297-301

About this book


This book provides an up-to-date evaluation of clinical aspects of newly available "long-circulating liposome" formulations. Based on results from numerous clinical studies, the book describes the fundamentals of this new technology, discusses how it may influence the pharmacology of existing well-known agents reformulated in this manner, and elaborates on future expectations. It provides the practicing clinician - in particular, oncologists and critical care infectious disease physicians - with the tools needed to use these new formulations towards the best outcome for the patient.


Arzneimittel Liposomen Onkologie drug drug design fatty acids infectious disease influence lipide lipids liposomes oncology pharmaceutical pharmacology tumor

Editors and affiliations

  • Martin C. Woodle
    • 1
  • Gerrit Storm
    • 2
  1. 1.Genetic Therapy, Inc.GaithersburgUSA
  2. 2.Department of PharmaceuticsUniversity of UtrechtUtrechtThe Netherlands

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1998
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-662-22117-4
  • Online ISBN 978-3-662-22115-0
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology
Consumer Packaged Goods